Financhill
Back

Altimmune 10K Form

Buy
70

ALT
Altimmune

Last Price:
12.10
Seasonality Move:
11.21%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ALT News And Ratings

See the #1 stock for the next 7 days that we like better than ALT

ALT Financial Statistics

Sales & Book Value

Annual Sales: $-68K
Cash Flow: $-20.49M
Price / Cash Flow: 0
Annual Sales: $2.85
Price / Book: 4.32

Profitability

EPS (TTM): -1.54000
Net Income (TTM): $-78.47M
Gross Margin: $17.91M
Return on Equity: -44.78%
Return on Assets: -40.48%

Altimmune Earnings Forecast

Key Altimmune Financial Ratios

  • The Gross Profit Margin over the past 9 years for ALT is 100.00%.
  • The Interest Expense is -0.01% of Operating Income.
  • Per Share Earnings over the last 18 years have been positive in 10 years.

Altimmune Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: ALT
CUSIP: 02155H
Website: altimmune.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 12.89
Quick Ratio: 12.24

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ALT Technical Analysis vs Fundamental Analysis

Buy
70
Altimmune (ALT) is a Buy

Is Altimmune a Buy or a Sell?

  • Altimmune stock is rated a Buy
    The current Altimmune [ALT] share price is $12.09. The Score for ALT is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.